Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q1 EPS of ($0.96), $0.90 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.